Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

Tony S.K. Mok; Kwok Chi Lam; Conrad Lee; Li Zhang; Herman Wong; Anthony T.C. Chan; Winnie Yeo; Anthony P.C. Yim; Karen Chak; Benny Zee

doi:10.1159/000086992

Phase II Randomized Study Comparing the Toxicity Profile of Gemcitabine plus Cisplatin with Gemcitabine plus Oral Etoposide in the Treatment of Advanced Non-Small Cell Lung Cancer

Oncology ◽

10.1159/000086992 ◽

2005 ◽

Vol 68 (4-6) ◽

pp. 485-492 ◽

Cited By ~ 11

Author(s):

Tony S.K. Mok ◽

Kwok Chi Lam ◽

Conrad Lee ◽

Li Zhang ◽

Herman Wong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Oral Etoposide ◽

Toxicity Profile ◽

Small Cell Lung

Download Full-text

Phase II study of prolonged oral etoposide in combination with intravenous cisplatin in advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/0169-5002(95)90693-2 ◽

1995 ◽

Vol 13 (2) ◽

pp. 223

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oral Etoposide ◽

Small Cell Lung

Download Full-text

A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly

Journal of Thoracic Oncology ◽

10.1097/01243894-200602000-00007 ◽

2006 ◽

Vol 1 (2) ◽

pp. 141-145 ◽

Cited By ~ 9

Author(s):

Yuh-Min Chen ◽

Reury-Perng Perng ◽

Chun-Ming Tsai ◽

Jacqueline Whang-Peng

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

The Elderly ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Phase II trial with weekly cisplatin (CDDP) and continously oral etoposide (VP-16) in advanced non-small cell lung cancer (NSCLC)

European Journal of Cancer ◽

10.1016/0959-8049(93)91521-l ◽

1993 ◽

Vol 29 ◽

pp. S162

Author(s):

R. Lopez ◽

R. Fernandez ◽

J.A. Virizuela ◽

J. Cueva ◽

E. Garcia ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Oral Etoposide ◽

Small Cell Lung ◽

Weekly Cisplatin

Download Full-text

A phase ii study of concurrent accelerated hyperfractionated radiotherapy and carboplatin/oral etoposide for elderly patients with stage iii non-small-cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(99)00006-1 ◽

1999 ◽

Vol 44 (2) ◽

pp. 343-348 ◽

Cited By ~ 38

Author(s):

Branislav Jeremic ◽

Yuta Shibamoto ◽

Biljana Milicic ◽

Slobodan Milisavljevic ◽

Nebojsa Nikolic ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oral Etoposide ◽

Small Cell Lung ◽

Hyperfractionated Radiotherapy

Download Full-text

P-212 Phase II study of induction chemotherapy with gemcitabineand vinorelbine followed by concurrent chemotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small cell lung cancer

Lung Cancer ◽

10.1016/s0169-5002(05)80706-8 ◽

2005 ◽

Vol 49 ◽

pp. S170

Author(s):

D. Lee ◽

K. Cho ◽

J. Han ◽

H. Pyo ◽

H. Kim ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Induction Chemotherapy ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

Oral Etoposide ◽

Small Cell Lung

Download Full-text

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095 ◽

Cited By ~ 2

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Study Results

Download Full-text

A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7095 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7095-7095

Author(s):

A. Mueller ◽

N. Thatcher ◽

C. Kortsik ◽

G. Koschel ◽

W. Spengler ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

Study Results

Download Full-text

Local consolidative therapy (LCT) to improve progression-free survival (PFS) in patients with oligometastatic non-small cell lung cancer (NSCLC) who receive induction systemic therapy (IST): Results of a multi-institutional phase II randomized study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.9004 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 9004-9004 ◽

Cited By ~ 4

Author(s):

Daniel Richard Gomez ◽

George R. Blumenschein ◽

J. Jack Lee ◽

Mike Hernandez ◽

D. Ross Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Systemic Therapy ◽

Randomized Study ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival

Download Full-text

A Phase II, Open-Label, Randomized Study to Assess the Efficacy and Safety of AZD6244 (ARRY-142886) Versus Pemetrexed in Patients with Non-small Cell Lung Cancer Who Have Failed One or Two Prior Chemotherapeutic Regimens

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181e8b3a3 ◽

2010 ◽

Vol 5 (10) ◽

pp. 1630-1636 ◽

Cited By ~ 122

Author(s):

John D. Hainsworth ◽

Cristina L. Cebotaru ◽

Vladimir Kanarev ◽

Tudor E. Ciuleanu ◽

Danail Damyanov ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Open Label

Download Full-text

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer

Annals of Oncology ◽

10.1093/annonc/mdu384 ◽

2014 ◽

Vol 25 (11) ◽

pp. 2156-2162 ◽

Cited By ~ 19

Author(s):

S. Novello ◽

B. Besse ◽

E. Felip ◽

F. Barlesi ◽

J. Mazieres ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Small Cell Lung ◽

First Line ◽

First Line Therapy ◽

Line Therapy

Download Full-text